Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 4 de 4
Filter
Add more filters










Database
Language
Publication year range
1.
Open Forum Infect Dis ; 9(7): ofac232, 2022 Jul.
Article in English | MEDLINE | ID: mdl-35832268

ABSTRACT

Background: Opaganib, an oral sphingosine kinase-2 inhibitor with antiviral and anti-inflammatory properties, was shown to inhibit severe acute respiratory syndrome coronavirus 2 replication in vitro. We thus considered that opaganib could be beneficial for moderate to severe coronavirus disease 2019 (COVID-19) pneumonia. The objective of the study was to evaluate the safety of opaganib and its effect on supplemental oxygen requirements and time to hospital discharge in COVID-19 pneumonia hospitalized patients requiring supplemental oxygen. Methods: This Phase 2a, randomized, double-blind, placebo-controlled study was conducted between July and December 2020 in 8 sites in the United States. Forty-two enrolled patients received opaganib (n = 23) or placebo (n = 19) added to standard of care for up to 14 days and were followed up for 28 days after their last dose of opaganib/placebo. Results: There were no safety concerns arising in this study. The incidence of ≥Grade 3 treatment-emergent adverse events was 17.4% and 33.3% in the opaganib and placebo groups, respectively. Three deaths occurred in each group. A numerical advantage for opaganib over placebo was observed in in this nonpowered study reflected by total supplemental oxygen requirement from baseline to Day 14, the requirement for supplemental oxygen for at least 24 hours by Day 14, and hospital discharge. Conclusions: In this proof-of-concept study, hypoxic, hospitalized patients receiving oral opaganib had a similar safety profile to placebo-treated patients, with preliminary evidence of benefit for opaganib as measured by supplementary oxygen requirement and earlier hospital discharge. These findings support further evaluation of opaganib in this population.

2.
Clin Pract Cases Emerg Med ; 3(3): 318-320, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31403108

ABSTRACT

We present a case of a patient who underwent ultrasound evaluation for potential blunt ocular trauma. She was found to have multiple, freely mobile, scintillating hyperechoic opacities within the vitreous that was diagnosed as asteroid hyalosis, a rare but benign condition easily confused with vitreous hemorrhage, retinal detachment, lens dislocation, or foreign body on ocular ultrasound.

3.
Am J Emerg Med ; 36(6): 1018-1021, 2018 Jun.
Article in English | MEDLINE | ID: mdl-29395763

ABSTRACT

INTRODUCTION: Retrospective data indicates that dehydration in acute ischemic stroke patients may be common, even though these patients frequently have elevated blood pressure. We sought to evaluate clinical and laboratory measures of intravascular volume status compared to more objective measures using ultrasound measurements of the inferior vena cava (IVC). METHODS: This was a prospective observation study of acute ischemic stroke patients in the emergency department. Patients with NIH stroke scale ≥4 within 12 h of symptom onset were included. A trained ultrasonographer performed bi-dimensional imaging of the IVC with passive respiration to determine the percent inspiratory collapse and maximum diameter. We defined low intravascular volume as >50% IVC collapse and a maximal diameter < 2.1 cm. Analysis was limited to patients with confirmed ischemic stroke. RESULTS: There were 42 patients, of whom 31 had confirmed acute ischemic stroke. The mean age was 65 ±â€¯15 years, 52% were female, and 71% were hypertensive. The median NIH stroke scale score was 7 (IQR 5-15). Based on IVC ultrasound, low intravascular volume was present in 63% (95% CI 44-80%) of patients. A higher proportion of hypertensive patients had low intrasvascular volume (72% vs. 33%). There was poor correlation between IVC assessment of intrasvascular volume and blinded clinician assessment or laboratory markers of dehydration. CONCLUSION: The majority of ED acute ischemic stroke patients in this sample were hypertensive and demonstrated low intravascular volume based on IVC ultrasound.


Subject(s)
Blood Volume Determination/methods , Brain Ischemia/diagnosis , Ultrasonography/methods , Vena Cava, Inferior/diagnostic imaging , Acute Disease , Aged , Blood Pressure/physiology , Brain Ischemia/physiopathology , Emergency Service, Hospital , Female , Follow-Up Studies , Humans , Male , Prospective Studies , Vena Cava, Inferior/physiology
4.
J Emerg Med ; 49(5): e151-2, 2015 Nov.
Article in English | MEDLINE | ID: mdl-26297112

ABSTRACT

BACKGROUND: The patient presenting in an undifferentiated shock state can produce a diagnostic challenge for even the most seasoned clinician. CASE REPORT: We present an unusual case of an elderly woman in obstructive shock from a large atrial mass that was promptly diagnosed with point-of-care ultrasound. WHY SHOULD AN EMERGENCY PHYSICIAN BE AWARE OF THIS?: Ultrasound is a non-invasive tool that can help facilitate the early diagnosis of a patient in undifferentiated shock.


Subject(s)
Adrenal Gland Neoplasms/pathology , Heart Neoplasms/diagnostic imaging , Shock/etiology , Aged , Echocardiography , Fatal Outcome , Female , Heart Atria/diagnostic imaging , Heart Neoplasms/complications , Heart Neoplasms/secondary , Humans , Point-of-Care Systems
SELECTION OF CITATIONS
SEARCH DETAIL
...